Roundtable Recap: May 18 – Spotlight on Customer Acquisition

During this week’s roundtable, our focus was on customer acquisition strategy.

Rezeve

First up, we had Adrian Ng from Singapore pitch Rezeve, a software for running small services businesses.

Youzentech Technologies

Next, we had Rajkapoor Singh from Bangalore, India, pitch Youzentech Technologies, a semiconductor chip verification company.

You can listen to the recording of this roundtable here:

>>>

Featured Videos

Cloud Stocks: Twilio Attempts Personalization

According to a recent report, the Unified Communications as a Service (UCaaS) market is expected to grow at 13% CAGR to reach $69.93 billion by 2028. Leading player Twilio (NYSE: TWLO) recently announced its first quarter results that outpaced market expectations. But the continuing macro-economic uncertainty has made it cautious as was evident in its outlook.

Building an AI-Powered Pharmaceutical Services Business: VIDA CEO Susan Wood (Part 5)

Sramana Mitra: What is the average deal size?

Susan Wood: In phase three, it’s in the order of $3 million to $5 million. I want to mention something else. When patients couldn’t go to a centralized site to get evaluated during COVID, they were shut out. The big push in the industry is what’s called decentralization of clinical trials. The trial comes to you.

I could be a nurse practitioner and you could be a subject. I’d say, “Take the drug now and we’ll take your blood pressure.” We can’t do that with imaging. Someday, I think we will. I can’t put a CT scan on your front yard easily. What we do is decentralize it. They would use decentralized imaging centers.

Video FAQs

Best of Bootstrapping: Bootstrapped a Product Using Services First

If you haven’t already, please study our Bootstrapping Course and Investor Introductions page. 

Here is yet another case study of a services company successfully bootstrapping a product, then raising Venture Capital. Here is my conversation with Bill Moschella, Co-founder of Evariant, from 2015. Healthgrades acquired Evariant in 2020.

Sramana Mitra: Let’s begin at the beginning of your personal story. Where are you from? Where were you born and raised? What’s the back story of your entrepreneurial story?

Bill Moschella: I was born and raised in Connecticut. I attended college at Berklee and eventually got my degree. What I was passionate about all of my life was music. I went to music school and graduated with a music degree. I left college playing music in a band and opened up a recording studio. I never really had a job. I was always playing music. I was running bands. I found that I had a passion for the engineering side of music so I opened up a recording studio. I took all the money that I saved up from gigs.

>>>

607th Roundtable for Entrepreneurs Starting NOW: Live Tweeting by @1Mby1M

Today’s 607th FREE online 1Mby1M Roundtable for Entrepreneurs is starting NOW, on Thursday, May 18, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. CLICK HERE to join. MEETING NUMBER: 2559 287 4514 PASSWORD: startup  All are welcome!

607th Roundtable for Entrepreneurs Starting in 30 Minutes: Live Tweeting by @1Mby1M

Today’s 607th FREE online 1Mby1M Roundtable for Entrepreneurs is starting in 30 minutes, on Thursday, May 18, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. CLICK HERE to join. MEETING NUMBER: 2559 287 4514 PASSWORD: startup  All are welcome!

Building an AI-Powered Pharmaceutical Services Business: VIDA CEO Susan Wood (Part 4)

Susan Wood: There are people out there who are walking around with a prevalence of lung disease that they’re not even aware of. You can have low-level or medium-level lung disease and not feel that much difference in your day-to-day life. When you have a pandemic and you have this acute impact on your respiratory system that has somewhat reduced the lung function anyway, those people would have poorer outcomes.

Sramana Mitra: On the consumer level, you had a lot more awareness?

Building an AI-Powered Pharmaceutical Services Business: VIDA CEO Susan Wood (Part 3)

Sramana Mitra: Did you succeed in raising venture capital?

Susan Wood: Within the state, yes. The last round was a couple of years ago. That was with First Analysis out of Chicago. I’ve got some Silicon Valley money, but mostly from Midwest.

Sramana Mitra: It’s a common storyline where you get the early-stage funding from the state through small VCs, and then the bigger funding from Chicago. This is a common Midwest story.